PhaseBio Pharmaceuticals, Inc. (PHAS)

Investing Cash Flow

-$2.40M

TTM · Period ending: · USD

PHAS logo

PHAS Investing Cash Flow

Latest reported-$2.40M
PHAS Cash from Investing ($9.25M → -$2.40M)
High-resolution chart · PNG

PHAS investing cash flow history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

PhaseBio Pharmaceuticals, Inc. Investing Cash Flow — Annual fiscal periods (USD)
Period endingInvesting Cash Flow (USD)
-2,679,000
-1,412,000
-960,000
-119,000
-216,000
9,249,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.